230 related articles for article (PubMed ID: 17379603)
1. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation.
Rebouissou S; Imbeaud S; Balabaud C; Boulanger V; Bertrand-Michel J; Tercé F; Auffray C; Bioulac-Sage P; Zucman-Rossi J
J Biol Chem; 2007 May; 282(19):14437-46. PubMed ID: 17379603
[TBL] [Abstract][Full Text] [Related]
2. Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis.
Pelletier L; Rebouissou S; Paris A; Rathahao-Paris E; Perdu E; Bioulac-Sage P; Imbeaud S; Zucman-Rossi J
Hepatology; 2010 Feb; 51(2):557-66. PubMed ID: 20041408
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
[TBL] [Abstract][Full Text] [Related]
4. HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines.
Pelletier L; Rebouissou S; Vignjevic D; Bioulac-Sage P; Zucman-Rossi J
BMC Cancer; 2011 Oct; 11():427. PubMed ID: 21975049
[TBL] [Abstract][Full Text] [Related]
5. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
[TBL] [Abstract][Full Text] [Related]
6. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.
Jeannot E; Poussin K; Chiche L; Bacq Y; Sturm N; Scoazec JY; Buffet C; Van Nhieu JT; Bellanné-Chantelot C; de Toma C; Laurent-Puig P; Bioulac-Sage P; Zucman-Rossi J
Cancer Res; 2007 Mar; 67(6):2611-6. PubMed ID: 17363580
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
10. Gene mutations in hepatocellular adenomas.
Raft MB; Jørgensen EN; Vainer B
Histopathology; 2015 Jun; 66(7):910-21. PubMed ID: 25195525
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
14. Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li N; Li M; Hong W; Shao J; Xu H; Shimano H; Lu J; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2881-2889. PubMed ID: 29857051
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice.
Akiyama TE; Ward JM; Gonzalez FJ
J Biol Chem; 2000 Sep; 275(35):27117-22. PubMed ID: 10852923
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
17. Curcumin protects against high-fat diet-induced nonalcoholic simple fatty liver by inhibiting intestinal and hepatic NPC1L1 expression via down-regulation of SREBP-2/HNF1α pathway in hamsters.
Yang J; Zou J; Mai H; Hong T; Liu H; Feng D
J Nutr Biochem; 2023 Sep; 119():109403. PubMed ID: 37307885
[TBL] [Abstract][Full Text] [Related]
18. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.
Xu X; So JS; Park JG; Lee AH
Semin Liver Dis; 2013 Nov; 33(4):301-11. PubMed ID: 24222088
[TBL] [Abstract][Full Text] [Related]
20. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway.
Xia M; Liu Y; Guo H; Wang D; Wang Y; Ling W
Hepatology; 2013 Aug; 58(2):564-75. PubMed ID: 23300015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]